Cargando…
The Knockdown of Nrf2 Suppressed Tumor Growth and Increased the Sensitivity to Lenvatinib in Anaplastic Thyroid Cancer
Papillary thyroid cancer can dedifferentiate into a much more aggressive form of thyroid cancer, namely into anaplastic thyroid cancer. Nrf2 is commonly activated in papillary thyroid cancer, whereas its role in anaplastic thyroid cancer has not been fully explored. In this study, we used two cell l...
Autores principales: | Gong, Zhongqin, Xue, Lingbin, Wei, Minghui, Liu, Zhimin, Vlantis, Alexander C., van Hasselt, C. Andrew, Chan, Jason Y. K., Li, Dongcai, Zeng, Xianhai, Tong, Michael C. F., Chen, George G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437598/ https://www.ncbi.nlm.nih.gov/pubmed/34527171 http://dx.doi.org/10.1155/2021/3900330 |
Ejemplares similares
-
The Isoforms of Estrogen Receptor Alpha and Beta in Thyroid Cancer
por: Gong, Zhongqin, et al.
Publicado: (2022) -
Differential Effects of Estrogen Receptor Alpha and Beta on Endogenous Ligands of Peroxisome Proliferator-Activated Receptor Gamma in Papillary Thyroid Cancer
por: Yang, Shucai, et al.
Publicado: (2021) -
Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017) -
Efficacy of lenvatinib in a patient with anaplastic thyroid cancer
por: Oishi, Kazuyuki, et al.
Publicado: (2017) -
Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer
por: Su, Xi, et al.
Publicado: (2020)